文献速递传染病防控与疫情报告免疫规划慢病防控与筛查

2016/17至2019/20年西班牙老年人基于人群队列的呼吸道合胞病毒住院研究

Hospitalisation due to respiratory syncytial virus in a population-based cohort of older adults in Spain, 2016/17 to 2019/20.
PubMed 文献 · Euro Surveill · 2025-01-01

该研究在西班牙纳瓦拉对60岁及以上成年人开展基于人群的队列研究,2016/17至2019/20流行季共分析642,622人年,检出544例经PCR确诊的呼吸道合胞病毒住院,年平均发病率为84.7/10万。高龄、养老院居住、功能依赖及部分合并症为独立危险因素,这些优先人群占全部呼吸道合胞病毒住院的50.7%。

要点

  • 60岁及以上成年人呼吸道合胞病毒住院年平均发病率为84.7/10万。
  • 75岁及以上人群住院率比高于3,85–94岁组约为7。
  • 养老院居住、功能依赖及血液肿瘤等合并症定义优先接种人群。

核心结论

  • 高龄、养老院居住、功能依赖及部分合并症定义了呼吸道合胞病毒疫苗接种的优先人群。

研究设计与样本

  • 基于人群的队列研究,纳入西班牙纳瓦拉2016/17至2019/20流行季60岁及以上成年人,共分析642,622人年。
  • 采用泊松回归评估危险因素。

主要发现

  • 共检出544例经PCR确诊的呼吸道合胞病毒住院,年平均发病率为84.7/10万。
  • 各流行季发病率在59.7/10万至95.6/10万之间波动。
  • 与60–64岁组相比,75岁及以上人群住院率比高于3,85–94岁组约为7。
  • 养老院居住、功能依赖、血液肿瘤、慢性阻塞性肺疾病、哮喘、心血管疾病、重度肥胖、糖尿病和慢性肾脏病为独立危险条件。
  • 血液肿瘤或养老院居住者、75岁及以上合并慢阻肺或功能依赖者、85岁及以上合并哮喘或心血管疾病者住院率高于300/10万,这些人群占全部60岁及以上成年人的13.2%,占其呼吸道合胞病毒住院的50.7%,平均每307人年发生1例住院。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of acute respiratory infection that can lead to complications in risk groups. AIM: We aimed to estimate the incidence of RSV hospitalisation in adults, determine the risk factors and characterise priority groups for prevention. METHODS: This population-based cohort study included adults 60 years and older in Navarre, Spain, in seasons 2016/17 to 2019/20. We estimated the rate of RSV hospitalisation confirmed by PCR and evaluated risk factors using Poisson regression. RESULTS: Within 642,622 person-years analysed, we detected 544 RSV hospitalisations (average annual rate: 84.7/100,000). The rate varied among seasons between 59.7 and 95.6 per 100,000. The rate ratio of hospitalisation was higher than 3 from the age of 75 years and around 7 in the 85–94 years age group compared with those aged 60–64 years. Nursing home residence, functional dependence, haematological cancer, chronic obstructive pulmonary disease (COPD), asthma, cardiovascular disease, severe obesity, diabetes and chronic kidney disease were independent risk conditions. Rate of RSV hospitalisation was higher than 300 per 100,000 among people with haematological cancer or nursing home residence, those aged ≥ 75 years with COPD or functional dependence, and those aged ≥ 85 years with asthma or cardiovascular disease. These groups represented 13.2% of all adults aged ≥ 60 years and 50.7% of their RSV hospitalisations. On average, these groups had one RSV hospitalisation per 307 person-years. CONCLUSION: Advanced age, in addition to nursing home residence, functional dependence and some comorbidities define priority groups for RSV vaccination.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Vera-Punzano N, Trobajo-Sanmartín C, Navascués A, et al. Hospitalisation due to respiratory syncytial virus in a population-based cohort of older adults in Spain, 2016/17 to 2019/20. Euro Surveill. 2025. PMID: 40084423. doi:10.2807/1560-7917.ES.2025.30.10.2400364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。